Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard

Background The prevalence of infection with non-tuberculous mycobacteria (NTM) has been increasing in people with cystic fibrosis (pwCF) over the past 30 years. Emerging reports of beneficial effects of CFTR modulators, particularly elexacaftor/tezacaftor/ivacaftor (ETI), on the rates of NTM acquisi...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Philip Masel, Rachel M Thomson, Daniel Smith, David W Reid, Daniel Henderson, Vanessa Moore, Timothy Riddles, Ieuan Edward Shepherd Evans, Andrew J Burke
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMJ Publishing Group 2025-12-01
Seri Bilgileri:	BMJ Open Respiratory Research
Online Erişim:	https://bmjopenrespres.bmj.com/content/12/1/e003204.full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard

Benzer Materyaller